子宫切除术与子宫肌瘤剔除术对子宫肌瘤患者一年健康相关生活质量的比较效果
本研究为前瞻性队列研究,纳入1113例接受子宫切除术或子宫肌瘤剔除术的绝经前子宫肌瘤患者,比较术后1年健康相关生活质量(HRQOL)。调整基线差异后,子宫切除术患者的HRQOL和症状严重程度改善显著优于肌瘤剔除术;按手术途径分层,微创子宫切除术的HRQOL评分优于微创肌瘤剔除术,而开腹途径两者差异很小。
要点
- 子宫切除术患者术后1年HRQOL和症状严重程度改善优于肌瘤剔除术。
- 微创子宫切除术的HRQOL评分优于微创肌瘤剔除术。
- 开腹子宫切除术与开腹肌瘤剔除术的HRQOL差异很小。
核心结论
- 子宫切除术或肌瘤剔除术后1年所有女性HRQOL均改善,子宫切除术患者报告的HRQOL汇总评分更高。
研究设计与样本
- 前瞻性队列研究,纳入美国8个临床中心的1113例接受子宫切除术或肌瘤剔除术的绝经前子宫肌瘤患者。
主要发现
- 调整基线差异后,与肌瘤剔除术相比,子宫切除术患者的HRQOL显著改善(95%CI 5.4, 17.2),症状严重程度显著改善(95%CI -16.3, -8.8)。
- 按种族/民族和年龄分层,子宫切除术的HRQOL评分均高于肌瘤剔除术。
- 开腹子宫切除术与开腹肌瘤剔除术的HRQOL差异很小(95%CI 0.1 [-9.5, 9.6]),症状严重程度差异也很小(95%CI -3.4 [-10, 3.2])。
临床怎么用
- 临床决策时可参考:子宫切除术在1年HRQOL改善上可能优于肌瘤剔除术,尤其微创途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare long-term health-related quality of life (HRQOL) 1 year after hysterectomy or myomectomy for treatment of uterine fibroids (UFs) and to determine whether route of procedure, race, or age affected improvements in HRQOL. DESIGN: Prospective cohort study. SETTING: Eight clinical sites throughout the United States. PATIENT(S): A total of 1,113 premenopausal women with UFs who underwent hysterectomy or myomectomy as part of Comparing Options for Management: Patient-Centered Results for Uterine Fibroids. INTERVENTION(S): None. MAIN OUTCOME MEASURE (S): Self-reported HRQOL measures including Uterine Fibroid Symptom Quality of Life, the European QOL 5 Dimension Health Questionnaire, and the visual analog scale at baseline and 1-year after hysterectomy or myomectomy. RESULT (S): Hysterectomy patients were older with a longer history of symptomatic UF compared with myomectomy patients. There were no differences in baseline HRQOL. After adjustment for baseline differences between groups, compared with myomectomy, patients' HRQOL (95% confidence interval [CI], 5.4, 17.2) and symptom severity (95% CI, -16.3, -8.8) were significantly improved with hysterectomy. When stratified across race/ethnicity and age, hysterectomy had higher HRQOL scores compared with myomectomy. There was little difference in HRQOL (95% CI, 0.1 [-9.5, 9.6]) or symptom severity (95% CI, -3.4 [-10, 3.2]) between abdominal hysterectomy and abdominal myomectomy. CONCLUSION (S): HRQOL improved in all women 1 year after hysterectomy or myomectomy. Hysterectomy patients reported higher HRQOL summary scores compared with myomectomy patients. When stratified by route, minimally invasive hysterectomy had better HRQOL scores than minimally invasive myomectomy. There was little difference in scores with abdominal approaches.
引用
- Wallace K, Zhang S, Thomas L, et al. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. Fertil Steril. 2020. PMID: 32192594. doi:10.1016/j.fertnstert.2019.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。